How gut microbes affect bone strength
The Microbiome and Bone Strength
This work tests whether certain gut bacteria and their products change bone tissue quality and strength in young and adult people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11379937 on NIH RePORTER |
What this research studies
From a patient's view, researchers are looking at the community of bacteria in the gut to find which microbes or microbial genes link to stronger or weaker bones. They will compare how the microbiome influences bone during growth versus after the skeleton is mature, use lab measurements of bone tissue quality and strength, and analyze microbial products like vitamin K and levels of bone proteins such as osteocalcin. Much of the work builds on animal and lab experiments but aims to identify targets that could one day be changed by treatments. The team will combine microbiome sequencing, biochemical assays, and bone mechanics testing to trace the pathway from gut microbes to bone strength.
Who could benefit from this research
Good fit: Adults concerned about bone health, including people at risk for low bone strength or willing to provide stool samples and clinical information, would be most relevant to this work.
Not a fit: People whose bone problems are primarily from known genetic skeletal disorders, recent major fractures, or conditions unrelated to gut biology may not benefit from microbiome-targeted approaches.
Why it matters
Potential benefit: If successful, this could lead to new microbiome-based ways to improve bone tissue quality and reduce fracture risk beyond current bone-density treatments.
How similar studies have performed: Preclinical animal studies have shown gut microbes can change bone strength, but applying those findings to human bone tissue quality and targeting microbial vitamin K pathways is relatively new.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Hernandez, Christopher John — University of California, San Francisco
- Study coordinator: Hernandez, Christopher John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.